Who is sponsoring NCT03064256?

NCT03064256 is sponsored by University of Campinas, Brazil.

What drugs are being tested in NCT03064256?

Interventions in NCT03064256: Physical training program, Physical training program.

What condition does NCT03064256 study?

NCT03064256 studies Autonomic Nervous System Diseases.

Is NCT03064256 still recruiting?

NCT03064256 is currently completed. Last updated 27 February 2017.

Last reviewed 2017-02-27 · How we verify

NCT03064256

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aerobic Physical Training and Heart Rate Variability in Hypertersion

Completed NA Last updated 27 February 2017

What this trial tests

NA trial testing Physical training program in Autonomic Nervous System Diseases in 63 participants. Completed in 16 January 2017.

Timeline

14 November 2014

Primary endpoint
21 December 2015

16 January 2017

Quick facts

Lead sponsor	University of Campinas, Brazil
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	63
Start date	14 November 2014
Primary completion	21 December 2015
Estimated completion	16 January 2017

Drugs / interventions tested

Physical training program
Physical training program

Conditions studied

Autonomic Nervous System Diseases — all drugs for Autonomic Nervous System Diseases →

Sponsor

University of Campinas, Brazil

Who can join

Adults 18 to 80, any sex, with Autonomic Nervous System Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compared the changes in the cardiovascular, hemodynamic and metabolic variables of hypertensive patients who received aerobic physical training with intensity determined by the protocol of double non-exhaustive efforts (DENE) with that of patients who received routine outpatient care 12 weeks after Entry into the study. 63 men and women participated in the study and were allocated in the intervention group (n = 42) and control group (n = 21).The following were performed: Cardiopulmonary exercise test (TECP) for evaluation of peak oxygen consumption (VO2peak), oxygen pulse and double product; DENE protocol for the determination of the intensity of the training. It was obtained the recording of the intervals between consecutive heart beats (iRR) to evaluate the autonomic modulation of the heart rate. Body mass index, waist circumference (AC), hip circumference (CQ) and Waist / hip ratio (WHR) were measured.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Autonomic Nervous System Diseases

Currently open trials in the same condition.

NCT07468383 — Basic and Clinical Study of Cardiac Ganglion Catheter Ablation for the Treatment of Significant Bradycardia · NA · recruiting
NCT06236945 — HUTT to Assess Cardiac Autonomic Nervous Function · recruiting

Other University of Campinas, Brazil trials

Trials by the same sponsor.

NCT06929676 — Assessment of Tooth Mobility After Non-surgical Periodontal Treatment Followed by Tooth Splinting · NA · enrolling by invitation
NCT07456163 — Influence of Zirconia Abutments on Peri-Implant Tissues in Single-Tooth Restorations · NA · recruiting
NCT06884475 — Evaluation of Implantoplasty in the Treatment of Peri-Implantitis. · NA · active not recruiting
NCT06450327 — Resistant Hypertension An Open, Complicated ("Cum Plicare") or Complex ("Cum Plexus") Syndrome? · recruiting
NCT06600867 — Method for Measuring Dental Mobility and Displacement Force · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03064256 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Campinas, Brazil
Last refreshed: 27 February 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03064256.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing